NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED

All News NeuroScientific Biopharmaceuticals Limited

Equities

NSB

AU0000012973

Market Closed - Australian S.E. Other stock markets 01:30:35 23/05/2024 BST			5-day change	1st Jan Change
0.043 ^AUD	-2.27%		-4.44%	-2.27%

03-20	NeuroScientific Biopharmaceuticals Secures AU$2 Million R&D Tax Rebate for Fiscal Year 2023; Shares Rise 6%	MT
02-27	NeuroScientific Biopharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NeuroScientific Biopharmaceuticals Secures AU$2 Million R&D Tax Rebate for Fiscal Year 2023; Shares Rise 6%	03-20	MT
NeuroScientific Biopharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-27	CI
NeuroScientific Biopharmaceuticals Limited Announces Changes to Board of Directors	12-04	CI
NeuroScientific Biopharmaceuticals CEO to Step Down	12-01	MT
NeuroScientific Biopharmaceuticals Limited Announces Resignation of Stephen Carter as CEO Effective 31 December 2023	12-01	CI
Linda Friedland Steps Down from the Board of NeuroScientific Biopharmaceuticals Limited, Effective 17 November 2023	11-16	CI
Neuroscientific Biopharmaceuticals Limited Announces Board Changes	11-12	CI
NeuroScientific Biopharmaceuticals Ltd Appoints Linda Friedland as Independent Non-Executive Director	18/10/23	CI
Neuroscientific Biopharmaceuticals Limited Announces Chief Executive Officer Changes	31/08/23	CI
NeuroScientific Biopharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2023	25/08/23	CI
Neuroscientific Biopharmaceuticals Announce Positive Treatment Effect in Multiple sclerosis Animal Study	14/03/23	CI
NeuroScientific Biopharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2022	27/02/23	CI
Neuroscientific Biopharmaceuticals Files New Patent for Multiple Sclerosis Treatment; Shares Jump 7%	05/12/22	MT
NeuroScientific Biopharmaceuticals Files A New Patent, Entitled "Neuroprotective Compositions and Methods"	04/12/22	CI
NeuroScientific Biopharmaceuticals Names Interim CEO; Shares Climb 12%	23/11/22	MT
NeuroScientific Biopharmaceuticals Limited Announces Appointment of Mr. Paul Rennie as Interim CEO	22/11/22	CI
NeuroScientific Biopharmaceuticals Limited Announces Management Changes	15/11/22	CI
NeuroScientific Biopharmaceuticals Ltd Announces Resignation of Matt Liddelow as Managing Director	09/09/22	CI
NeuroScientific Biopharmaceuticals Ltd Announces Resignation of Matt Liddelow as CEO	09/09/22	CI
Neuroscientific Biopharmaceuticals Ltd. Announces HREC Decision to Not Approve Phase I Clinical Trial	06/09/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News NeuroScientific Biopharmaceuticals Limited

Equities

NSB

AU0000012973

All News

Filters